Collegium Pharmaceutical
COLL
$36.42
Share price
1.62%
Change (1 day)
59.46%
Change (1 year)
Categories
Collegium Pharmaceutical (COLL) - P/B ratio
P/B ratio as of April 2024 : 6.10
According to Collegium Pharmaceutical
's latest financial reports the company has a price-to-book ratio of 6.10.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Collegium Pharmaceutical - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 5.14 | 28.49% |
| 2022-12-31 | 4.00 | 25.62% |
| 2021-12-31 | 3.18 | -14.54% |
| 2020-12-31 | 3.72 | -53.03% |
| 2019-12-31 | 7.93 | 27.11% |
| 2018-12-31 | 6.24 | 7.98% |
| 2017-12-31 | 5.78 | 74.9% |
| 2016-12-31 | 3.30 | -50.75% |
| 2015-12-31 | 6.70 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 United Therapeutics UTHR | 1.84 | -69.85% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | -0.2210 | -103.62% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | 5.01 | -17.77% | 🇮🇪 Ireland |
 KemPharm KMPH | 2.34 | -61.69% | 🇺🇸 USA |